|
bextra
side effects include the following:
Potential
for increased risk of cardiovascular events
Gastrointestinal
bleeding
Serious
skin reactions, some resulting in death.
If
you are currently taking Bextra check with your doctor.
Withdrawal
On
April 7, 2005 the FDA announced that it has asked Pfizer, Inc.
to withdraw Bextra from the market "because the overall
risk versus benefit profile for the drug is unfavorable."
| FDA
INFORMATION |
| To read the
FDA's announcement withdrawing
Bextra. |
| To
report any unexpected adverse or serious events associated
with the use of Bextra® contact the FDA MedWatch program
on the internet or at 1-800-FDA-1088 |
Bextra?
Bextra® is a non-steroidal anti-inflammatory drug
(NSAIDs), known as a COX-2 selective agent. It is
prescribed for inflammation and pain from arthritis or menstrual
cramping. Other drugs in this class include Celebrex® and
Vioxx®. Bextra® and Celebrex® are both marketed by
Pharmacia Corporation and Pfizer
and Vioxx® is manufactured by Merck. Doctors switched patients
from Vioxx® to Bextra® when Merck voluntarily removed it from the
market due studies showing an increased risk for heart attack
and stroke.
bextra
site map
Autism
Education Materials!
|
